SEC 13F Intelligence

Birch Grove Capital LP / BMRN

Birch Grove Capital LP’s Biomarin Pharmaceutical Inc Position

Does Birch Grove Capital LP own Biomarin Pharmaceutical Inc (BMRN)? Not currently — the last reported position was 30.9K shares worth $3M in Q4 2021; the fund’s latest 13F (Q3 2024) no longer reports it.

Position Value
$3M
Q4 2021
Shares
30.9K
% of Portfolio
+1.23%
Quarters Held
6
position exited

Position History BMRN

Reported value by quarter
Q3 ’20: $2MQ3 ’20Q4 ’20: $3MQ4 ’20Q1 ’21: $3MQ1 ’21Q2 ’21: $3MQ2 ’21Q3 ’21: $2MQ3 ’21Q4 ’21: $3MQ4 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q4 202130.9K$3M+1.23%
Q3 202130.9K$2M+1.12%
Q2 202135.4K$3M+1.43%
Q1 202135.4K$3M+1.16%
Q4 202033.4K$3M+1.53%
Q3 202026.6K$2M+1.10%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Birch Grove Capital LP’s full portfolio or all institutional holders of BMRN.